Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Cancer
|
August 8, 2017
Cancer survivorship and opioid prescribing rates: A population-based matched cohort study among individuals with and without a history of cancer
Rinku Sutradhar, Armend Lokku, Lisa Barbera
American Journal of Perinatology
|
September 21, 2016
Trends and Outcomes of Patent Ductus Arteriosus Treatment in Very Preterm Infants in Canada
Armend Lokku, Lucia Mirea, Shoo K Lee, et al.
Arthritis Care & Research
|
January 18, 2023
Probability of Response in the First Sixteen Weeks After Starting Biologics: An Analysis of Juvenile Idiopathic Arthritis Biologics Trials
Lily Siok Hoon Lim, Armend Lokku, Eleanor Pullenayegum, et al.
BMC Medical Research Methodology
|
May 31, 2020
Summarizing the extent of visit irregularity in longitudinal data
Armend Lokku, Lily S Lim, Catherine S Birken, et al.
The International Journal of Biostatistics
|
August 15, 2021
Quantifying the extent of visit irregularity in longitudinal data
Armend Lokku, Catherine S Birken, Jonathon L Maguire, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique
|
December 28, 2016
Trends in unintentional injury mortality in Canadian children 1950-2009 and association with selected population-level interventions
Sarah A Richmond, Jennifer D'Cruz, Armend Lokku, et al.
Pediatric Rheumatology Online Journal
|
July 30, 2022
Latent classes of early response trajectories to biologics initiation in juvenile idiopathic arthritis: an analysis of four trials
Lily Siok Hoon Lim, Shamsia Shobhan, Armend Lokku, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 27, 2021
Efficacy, Safety, and Pharmacodynamic Effects of the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib (GDC-0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Trial
David Isenberg, Richard Furie, Nicholas S Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 8, 2024
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma
Christopher L Moertel, Angela C Hirbe, Hans H Shuhaiber, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Cancer
|
August 8, 2017
Cancer survivorship and opioid prescribing rates: A population-based matched cohort study among individuals with and without a history of cancer
Rinku Sutradhar, Armend Lokku, Lisa Barbera
American Journal of Perinatology
|
September 21, 2016
Trends and Outcomes of Patent Ductus Arteriosus Treatment in Very Preterm Infants in Canada
Armend Lokku, Lucia Mirea, Shoo K Lee, et al.
Arthritis Care & Research
|
January 18, 2023
Probability of Response in the First Sixteen Weeks After Starting Biologics: An Analysis of Juvenile Idiopathic Arthritis Biologics Trials
Lily Siok Hoon Lim, Armend Lokku, Eleanor Pullenayegum, et al.
BMC Medical Research Methodology
|
May 31, 2020
Summarizing the extent of visit irregularity in longitudinal data
Armend Lokku, Lily S Lim, Catherine S Birken, et al.
The International Journal of Biostatistics
|
August 15, 2021
Quantifying the extent of visit irregularity in longitudinal data
Armend Lokku, Catherine S Birken, Jonathon L Maguire, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique
|
December 28, 2016
Trends in unintentional injury mortality in Canadian children 1950-2009 and association with selected population-level interventions
Sarah A Richmond, Jennifer D'Cruz, Armend Lokku, et al.
Pediatric Rheumatology Online Journal
|
July 30, 2022
Latent classes of early response trajectories to biologics initiation in juvenile idiopathic arthritis: an analysis of four trials
Lily Siok Hoon Lim, Shamsia Shobhan, Armend Lokku, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
May 27, 2021
Efficacy, Safety, and Pharmacodynamic Effects of the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib (GDC-0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double-Blind, Placebo-Controlled Trial
David Isenberg, Richard Furie, Nicholas S Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 8, 2024
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma
Christopher L Moertel, Angela C Hirbe, Hans H Shuhaiber, et al.
Page
of 1